The Elsevier Office of Continuing Medical Education and AcademicCME appreciate your opinions to help assist us in the evaluation of the effectiveness of this activity and to identify your ongoing educational needs.

You must complete this evaluation form to receive acknowledgement for completing this activity.

*
*
*
*
*
*
*
*
Please use the scale: 1=Poor, 2=Fair, 3=Good, 4=Very good, 5=Excellent
12345
Review and analyze the current clinical trial data for CFTR modulator therapeutics to develop effective individualized treatment plans.
Discuss the details of real-world outcomes for patients treated with CFTR-based therapeutics.
Apply the principles of early diagnosis and early pharmaco-therapeutic intervention to the pediatric cystic fibrosis population.
Understand the science of developing therapeutic options for treating a larger population of cystic fibrosis patients.
*
Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable for me
12345N/A
Monitor recent advances in CFTR-based therapeutics to improve long-term outcomes in patients with cystic fibrosis.
Include shared decision making with your patients when developing personalized treatment plans.
*
Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable for me
12345N/A
Monitor recent advances in CFTR-based therapeutics to improve long-term outcomes in patients with cystic fibrosis.
Include shared decision making with your patients when developing personalized treatment plans.
*
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Overall, the activity met my learning needs
The information presented was without promotional or commercial bias
Was scientifically rigorous and evidence based
Provided appropriate and effective opportunities for active learning (e.g., discussion, Q&A)
The quality of the educational process was satisfactory and appropriate
Promoted improvements or quality in health care
The information provided with regard to faculty financial relationships met my needs for disclosure
The speakers were knowledgeable and presented the information clearly
The format of the discussion was relevant and enhanced my knowledge of the subject
*
Please use the scale: 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent
12345
John P. Clancy, MD
Gregory Sawicki, MD, MPH
Isabelle Fajac, MD, PhD
Manu Jain, MD
Debbie S. Benitez, RN, MSN, ACNP-BC
Steven M. Rowe, MD
*
*

Attestation to time spent on activity:

The Elsevier Office of Continuing Medical Education designates this live activity for a maxiumum of 2.0 AMA PRA Category 1 CreditsTM.

*